N/A
Completed N=31
Survivor mHealth: Wearable Devices in Cancer Survivors
Source: ClinicalTrials.gov NCT05417438 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcomePrimary: Feasibility of Enrollment — 30 Participants
Summary
The Survivor mobile health (mHealth) study is testing the use of wearable devices (Fitbits) and a smartphone application in cancer survivors. The goal of the program is to increase survivor's physical activity levels. The Fitbit will be synced to the app and participants will receive messages and notifications about their activity levels. Participants will also complete surveys through the app asking how useful it is and ways to improve it. The study team will conduct qualitative interviews at the completion of the 3 months to see how participants liked the program, and ways it can be improved and make it more specific to cancer survivors. The study team will also conduct interviews with providers and clinic staff to assess their perceptions of patient digital health programs and preferences for receiving patient-generated health data.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Enrollment |
30 | — |
| SECONDARY 3-month Daily Step Count |
6687 | — |
| SECONDARY 1-Month Usability Overall APP Rating |
3.79 | — |
Eligibility Criteria
Aims 1 and 2 Inclusion Criteria:
- Past cancer diagnosis
- At least 18 years of age
- Capacity to provide informed consent
- Medically cleared to perform physical activity (as noted by Physical Activity Readiness Questionnaire form or physician's clearance if needed)
- Owns a smartphone
Aims 1 and 2 Exclusion Criteria:
- Is a prisoner
- Non-English speaking
- Is unable to provide consent
- Under 18 years of age
- No prior cancer diagnosis
- Does not own a smartphone
Aim 3 Inclusion Criteria:
- Are a current UMass Memorial Cancer Clinic patient navigator, oncologist, radiologist, or cardiologist
- Consent to participate
Aim 3 Exclusion Criteria:
- Not currently employed at UMass Memorial
- Not involved in direct treatment of care coordination of cancer patients
Data sourced from ClinicalTrials.gov (NCT05417438). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.